Beperminogene perplasmid

DB19236InvestigationalGene Therapies

Beperminogene perplasmid is under investigation in clinical trial NCT02144610 (Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia).

Mechanism: Pharmacologically active on Hepatocyte growth factor receptor
Curator reviewed
Also known as: Dna (human hepatocyte growth factor plasmid pvax1 cdna) · Dna (plasmid pvax1hgf/mgbi)

Resolves to

Compound

UNIIQAW7PHB7H8CAS627861-07-8

Clinical / RWD

ATCC05XX01

Targets

P08581MET

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 1 drug category

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Beperminogene perplasmid, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account